RECENT NEWS

An inexpensive, accurate test that detects infections with the parasite Toxoplasma gondii can provide results within 30 minutes from a finger-prick in a doctor’s office or within an hour from a small blood sample tested in a local medical laboratory.

Thousands of cancer patients in England are set to gain fast-tracked access to trials of personalised cancer vaccines following the launch of a world-leading NHS ‘matchmaking’ service to help find new life-saving treatments.

Digital pathology and AI firm Paige has announced the launch of a new service line based on its Foundation Models, including the world's largest multi-modal AI model in pathology and oncology.

The World Health Organization (WHO) has released its updated Bacterial Priority Pathogens List (BPPL) 2024, featuring 15 families of antibiotic-resistant bacteria grouped into critical, high and medium categories for prioritisation. The list provides guidance on the development of new and necessary treatments to stop the spread of antimicrobial resistance (AMR).

INTEGRA Biosciences has released a new eBook providing a complete guide to next generation sequencing (NGS).

Bosch Healthcare Solutions has developed a PCR test for detecting Candida auris (C. auris) on the Vivalytic platform. The test is a global innovation now available for order from distribution partners including Randox Laboratories and R-Biopharm.

Jerusalem-based startup Salignostics, which develops and provides rapid tests based on saliva samples, has signed a cooperation agreement with ARC Innovation - the innovation arm of Sheba Medical Center. The agreement aims to develop a test for detecting oral cavity cancer based on saliva samples.

A joint study carried out by US health group Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model that will lay the foundation to improve patient outcomes and advance individually tailored care has been published in Nature.

A study, presented at the 61st European Renal Association (ERA) Congress, has uncovered a significant breakthrough in the diagnosis and monitoring of kidney diseases associated with nephrotic syndrome.

A 'new era' in medical diagnostics and patient care in Dorset was celebrated as NHS staff and partners gathered recently, to witness patient Steve Hiorns officially open the state-of-the-art Dorset Pathology Hub.

Point-of-care diagnostics company Nanopath has been awarded $4 million in funding from US Federal agencies. The company was awarded a $3 million grant from the National Institutes of Health (NIH) and a $1 million grant from the National Science Foundation (NSF) to support continued research and development of the company's point-of-care diagnostic platform for pelvic and gynaecologic infections.

Roche and Hitachi High-Tech have announced the extension of the partnership between the two companies, committing to at least 10 years of additional collaboration. Bringing together Roche and Hitachi’s expertise and track record in diagnostics innovation, engineering and manufacturing, the renewed contract further strengthens the long-lasting partnership.

NHS patients in England are set to benefit from faster access to new medical technologies under new plans. Proposals set out in a joint NHS England and NICE consultation outline a new route for medtech developers to access NHS funding to fast-track clinically and cost-effective products for use by the healthcare system.

The Medicines and Healthcare products Regulatory Agency (MHRA) has published a statement of policy intent for international recognition of medical devices.

The Australian Centre for the Prevention of Cervical Cancer (ACPCC), a not-for-profit organisation with 60 years of expertise in cervical cancer prevention, has partnered with Cirdan to implement a state-of-the-art laboratory information management system (LIMS) to optimise and future-proof its laboratory workflows.

BIVDA has welcomed a statement of policy intent published by MHRA for recognition by the UK of approvals of medical devices from international regulators.

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a four-week consultation which will support improved safety for certain high-risk IVD devices.

Karius has announced that its Karius Test has been granted designation as a Breakthrough Device from the Center for Devices and Radiological Health (CDRH) of the US FDA, for use in the diagnosis and management of immunocompromised patients with suspected lung infections including lower respiratory infection and pneumonia.

Ibex Medical Analytics and Kameda Medical Center (Kameda), both feature in a newly published clinical study evaluating Ibex's Galen platform, which demonstrated excellent outcomes in detecting cancer and other pathologies in prostate and breast biopsies.

Sysmex has been recognised in the ‘Great Place to Work’ scheme, receiving the 41st position in the ‘Best Workplaces 2024 – Large Category’ list, after being certified last November. In 2023 Sysmex UK was also recognised as a Great Place to Work for wellbeing.